Indeed, activation of cGAS or STING with pharmaceutical treatment induced IFN response and inhibited viral replication in HBV-infected human hepatoma cells and immortalized mouse hepatocytes (50, 51). This evidence concerns the gene CGAS and hepatocellular carcinoma.